ACCELERATE

Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at a High Risk for Vascular Outcomes (HRVD) – the ACCELERATE Study

Stage: klaar
Medicine: evacetrapib
Population: ASCVD
Phase: III
First Patient In: 1 October 2012
Last Patient In: 1 September 2013
Last Patient Last Visit: -

Study Director

drs. B.J.B. Hamer

Cardioloog